Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Financial reporting structure and trading update

9 Oct 2025 07:00

RNS Number : 6410C
Johnson Matthey PLC
09 October 2025
 

Re-classification of Catalyst Technologies reporting segment and pre-close trading update

9th October 2025

 

 

Re-classification of Catalyst Technologies

As announced on 22nd May 2025, we have agreed the sale of our Catalyst Technologies business to Honeywell International Inc. We continue to make progress on both regulatory approvals and the carve-out of the business, and expect the transaction to complete by the first half of calendar year 2026.

For the 2025/26 financial year, Catalyst Technologies will be reported as a discontinued operation in accordance with IFRS 5. Consequently, the headline financials to be published for the group (sales and underlying operating profit) will exclude Catalyst Technologies. To aid comparison of our results with prior periods, we have provided a breakdown of sales and underlying operating profit by business for the year ended 31st March 2025 in the appendix on page 3.

Pre-close trading update for the half year ended 30th September 2025

Johnson Matthey also releases a pre-close trading update for the half year ended30th September 2025, ahead of its half year results scheduled for 20th November 2025.

We expect strong performance in group underlying operating profit for the half year (excluding Catalyst Technologies and Value Businesses), driven by ongoing efficiency improvements across the group, together with strong trading in the PGM Services business.

We are also making encouraging progress in terms of cash performance. Although group free cash flow in the first half is expected to be an outflow, we expect to report a significantyear-on-year improvement in the first half (1H 2024/25: £169 million outflow¹). As we further embed our working capital improvement measures, we expect a material step up in free cash flow for the full year when compared to the prior year (2024/25: £59 million inflow¹).

The group outlook for the full year (excluding Catalyst Technologies and Value Businesses) is at the higher end of our initial guidance of mid single digit growth in underlying operating profit². Overall group performance will continue to be weighted towards the second half. If precious metal prices and foreign exchange rates remain at their current levels³ for the remainder of 2025/26, we now expect a c.£10 million net benefit to full year operating performance compared with the prior year (previously £5 million net adverse impact as guided in May 2025).⁴,⁵

Discontinued operations: Catalyst Technologies underlying operating profit in the first half is expected to be materially down year-on-year, impacted by weaker demand for catalysts and the timing of licensing wins in key end markets. The long-term growth potential for this business remains strong, with additional large-scale project wins in the half and a healthy project pipeline in our sustainable technologies portfolio.

Half year results

We will announce our half year results for the six months ended 30th September 2025 on20th November 2025.

ENDS

 

Enquiries: 

Investor Relations

 

 

Louise Curran

Head of Investor Relations

+44 20 7269 8235

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774

Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

Notes:

1. 

Net cash flow from operating activities after net interest paid, net purchases of non-current assets and investments, dividends received from joint ventures and associates and the principal elements of lease payments, adjusted for the impact of the disposal of Value Businesses and to reflect the classification of Catalyst Technologies as a discontinued operation.

2. 

Mid single digit percentage growth in pro-forma underlying operating profit at constant precious metal prices and constant currency. Baseline is underlying operating profit excluding Catalyst Technologies and Value Businesses(£298 million in 2024/25 as shown on page 3).

3. 

Precious metal prices and average foreign exchange rates on 31st August 2025.

4. 

If precious metal prices remain at their current level³ for the remainder of 2025/26 there would be a benefit ofc.£15 million on full year operating performance compared with the prior year. As provided in May 2025, a US$100 per troy ounce change in the average annual platinum, palladium and rhodium metal prices each have an impact of approximately £1 million, £1 million and £0.5 million respectively on full year 2025/26 underlying operating profit in PGM Services. This assumes no foreign exchange movement.

5. 

If foreign exchange rates remain at their current level³ (£:US$ 1.35, £:€ 1.16, £:RMB 9.62, £:INR 119) translational foreign exchange movements for the year ending 31st March 2026 are expected to adversely impact underlying operating profit by c.£5 million.

 

 

Appendix

Subject to completion of the Catalyst Technologies sale, below we have provided 2024/25 sales and underlying operating profit, excluding Catalyst Technologies (discontinued) and Value Businesses (divested).

 

Sales excluding precious metal¹

(£ million)

Year ended 31st March 2025

 

1H

2H

FY

 

Clean Air

1,165

1,154

2,319

PGM Services²

215

266

481

Hydrogen Technologies

20

40

60

Eliminations

(34)

(32)

(66)

Total sales (pro-forma)

1,366

1,428

2,794

 

Catalyst Technologies (discontinued)²,³

328

324

652

 

Eliminations (discontinued)⁴

(8)

(5)

(13)

 

Value Businesses (divested)⁵

36

1

37

 

Total sales (as reported)

1,722

1,748

3,470

 

Underlying operating profit

(£ million)

Year ended 31st March 2025

 

1H

2H

FY

 

Clean Air

121

152

273

PGM Services²

51

100

151

Hydrogen Technologies

(26)

(13)

(39)

Corporate

(42)

(45)

(87)

Total underlying operating profit (pro-forma)

104

194

298

 

Catalyst Technologies (discontinued)²,³

50

40

90

 

Value Businesses (divested)⁵

2

(1)

1

 

Total underlying operating profit (as reported)

156

233

389

 

 

Notes:

1.

Revenue excluding cost of precious metals to customers and the precious metal content of products sold to customers.

2.

Adjusted to reflect the group's updated reporting segments following the agreed sale of Catalyst Technologies, where a small business outside of the sale perimeter will move from Catalyst Technologies to PGM Services.

3.

Catalyst Technologies is classified as a discontinued operation for the financial year 2025/26.

4.

Relates to Catalyst Technologies.

5.

Value Businesses includes Battery Materials, Battery Systems and Medical Device Components which are all now disposed.

 

http://www.rns-pdf.londonstockexchange.com/rns/6410C_1-2025-10-8.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZMGGRRNGKZM
Date   Source Headline
3rd Jun 20269:03 amRNSDirector/PDMR Shareholding
2nd Jun 20264:40 pmRNSDirector/PDMR Shareholding
1st Jun 20264:02 pmRNSHolding(s) in Company
28th May 20267:05 amRNSBoard Changes
28th May 20267:01 amRNSJohnson Matthey acquisition of Cormetech
28th May 20267:00 amRNSJohnson Matthey Full Year Results
14th May 202611:42 amRNSDirector/PDMR Shareholding
16th Apr 202611:51 amRNSDirector/PDMR Shareholding
24th Mar 202611:30 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSDirector Declaration
24th Feb 20263:30 pmRNSDirector/PDMR Shareholding
24th Feb 20269:48 amRNSDirector/PDMR Shareholding
23rd Feb 20265:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20267:00 amRNSUpdate on Catalyst Technologies sale
12th Feb 202612:44 pmRNSDirector/PDMR Shareholding
14th Jan 20262:22 pmRNSDirector/PDMR Shareholding
8th Jan 202610:01 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
29th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20254:51 pmRNSDirector/PDMR Shareholding
20th Nov 20257:00 amRNSDirectorate change
20th Nov 20257:00 amRNSJohnson Matthey Half Year Results
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
24th Oct 202511:29 amRNSHolding(s) in Company
21st Oct 20253:44 pmRNSHolding(s) in Company
13th Oct 202511:55 amRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSFinancial reporting structure and trading update
3rd Oct 202510:23 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSHolding(s) in Company
26th Sep 20255:29 pmRNSHolding(s) in Company
17th Sep 20259:00 amRNSDirector Declaration
15th Sep 20252:37 pmRNSHolding(s) in Company
11th Sep 20254:13 pmRNSDirector/PDMR Shareholding
8th Sep 20256:00 pmRNSHolding(s) in Company
4th Sep 20255:19 pmRNSHolding(s) in Company
2nd Sep 20254:07 pmRNSHolding(s) in Company
29th Aug 202512:05 pmRNSTotal Voting Rights
26th Aug 20252:07 pmRNSDirector/PDMR Shareholding
13th Aug 20254:38 pmRNSDirector/PDMR Shareholding
13th Aug 20251:51 pmRNSDirector/PDMR Shareholding
5th Aug 20255:19 pmRNSHolding(s) in Company
5th Aug 20254:50 pmRNSDirector/PDMR Shareholding
25th Jul 20252:12 pmRNSHolding(s) in Company
23rd Jul 20252:23 pmRNSHolding(s) in Company
18th Jul 202512:07 pmRNSDirector/PDMR Shareholding
18th Jul 20259:18 amRNSHolding(s) in Company
17th Jul 20252:20 pmRNSResult of AGM
17th Jul 20257:00 amRNSAppointment of Andrew Cosslett as Chair
9th Jul 20254:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.